Nowa wersja platformy jest już dostępna.
Przejdź na


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2013 | 11 | 5 | 645-654
Tytuł artykułu

The use of mass spectrometry in obstetric and gynecology

Treść / Zawartość
Warianty tytułu
Języki publikacji
The present review shows the utility of using mass spectrometry (MS) in obstetrics and gynecology. In this review different gas chromatography / mass spectrometry and liquid chromatography / mass spectrometry methods developed before to be used in obstetrics and gynecology are described. These methods are very useful to determine different hormones in pregnancy, fatty acids esters (related to the use of ethanol) in human meconium and toxic compounds in umbilical cord (as ethanol, steroids, morphine, cocaine, methadone and other drugs). It is also shown in this review the progress during last decades in the field of using mass spectrometry in obstetrics and gynecology (for screening in utero exposure of the child to alcohol, drugs and other toxic compounds). In the field of using mass spectrometry in obstetrics and gynecology are still many problems to solve. For example, the detection of fatty acids esters in meconium has several limitations, which affects the results. One limitation is multiple births. Also in fetal distress, meconium may be passed before birth, and in this case, the collection is impossible. Moreover the meconium is formed starting from the fourth month of pregnancy, so the fetal exposure at any toxic compounds during the first three months cannot be detected at all. To solve all of these, the best would be to combine the results obtained from meconium, with other results obtained from pregnancy serum, placenta or umbilical cord. The main reason for using MS in obstetrics and gynecology is that MS is a noninvasive and a complementary method. It offers the results at a very early point in time, even before the act of birth. Sometimes the use of mass spectrometry is the only alternative. This shows that these methods are of great interest for the future and need to be developed further. [...]
Słowa kluczowe

Opis fizyczny
  • Department of Organic Chemistry, Institute of Chemistry of Romanian Academy, 300223, Timisoara, Romania
  • University of Medicine and Pharmacy “Victor Babes”, 300041, Timisoara, Romania
  • Obstetrics and Gynecology Hospital, 300172, Timisoara, Romania
  • Department of Organic Chemistry, Institute of Chemistry of Romanian Academy, 300223, Timisoara, Romania,
  • [1] M. Karas, F. Hillenkamp, Analytical Chemistry 60, 2299 (1988)[Crossref]
  • [2] F. Hillenkamp, M. Karas, R.C. Beavis, B.T. Chait, Analytical Chemistry 63, 1193A (1991)
  • [3] C.E. Dalgliesh, E.C. Horning, M.G. Horning, K.L. Knox, K. Yarger, J. Biochem. 101, 792 (1966)
  • [4] M.G. Horning, L.D. Waterbury, E.C. Horning, R.M. Hill, Placental transfer of drugs: Drugs and drug metabolites in the neonate (Exc. Medica Foundation, Amsterdam, 1969)
  • [5] H.W. Lahm, H. Langen, Electrophoresis 21, 2105 (2000)<2105::AID-ELPS2105>3.0.CO;2-M[Crossref]
  • [6] A. Pandey, M. Mann, Nature 405, 837 (2000)[Crossref]
  • [7] W.H. McDonald, J.R. Yates, Traffic 1, 747 (2000)[Crossref]
  • [8] R. Aebersold, D.R. Goodlett, Chemical Reviews 101, 269 (2001)[Crossref]
  • [9] J. Godovac-Zimmermann, L.R. Brown, Mass Spectrometry Reviews 20, 1 (2001)<1::AID-MAS1001>3.0.CO;2-J[Crossref]
  • [10] M. Stoeckli, P. Chaurand, D.E. Hallahan, R.M. Caprioli, Nature Medicine 7, 493 (2001)[Crossref]
  • [11] Y.I. Goh, J.R. Hutson, L. Lum, H. Roukema, J. Gareri, H. Lynn, Alcohol 44, 629 (2010)[Crossref]
  • [12] C.F. Bearer, L.M. Santiago, M.A. O’Riordan, K. Buck, S.C. Lee, L.T. Singer, The Journal of Pediatrics 146, 824 (2005)[Crossref]
  • [13] C.F. Bearer, J.L. Jacobson, S.W. Jacobson, D. Barr, J. Croxford, C.D. Molteno, D.L. Viljoen, A.-S. Marais, L.M. Chiodo, A.S. Cwik, Journal of Pediatrics. 143, 463 (2003)[Crossref]
  • [14] D. Chan, D. Caprara, P. Blanchette, J. Klein, G. Koren, Clinical Biochemistry 37, 429 (2004)[Crossref]
  • [15] D. Chan, B. Knie, R. Boskovic, G. Koren, Journal of Pharmacology and Experimental Therapeutics 310, 75 (2004)[Crossref]
  • [16] J. Gareri, H. Lynn, M. Handley, C. Rao, G. Koren, Therapeutic Drug Monitoring 30, 239 (2008)[Crossref]
  • [17] National Institute of Child Health and Human Development, (2006)
  • [18] J.R. Hutson, K. Aleksa, F. Pragst, G. Koren, Journal of chromatography B. 877, 8 (2009)[Crossref]
  • [19] F. Pragst, V. Auwaerter, F. Sporkert, K. Spiegel, Forensic Science International 121, 76 (2001)[Crossref]
  • [20] K.D. Stark, S. Beblo, M. Murthy, M. Buda-Abela, J. Janisse, H. Rockett, J.E. Whitty, S.S. Martier, R.J. Sokol, J.H. Hannigan, N. Salem Jr., Journal of Lipid Research 46, 516 (2005)[Crossref]
  • [21] M. Sarkar, M. Burnett, S. Carriere, L.V. Cox, C.A. Dell, H. Gammon, B. Geller, G. Koren, L. Lee, D. Midmer, P. Mousmanis, N. Schuurmans, V. Senikas, D. Soucy, R. Wood, The Canadian Journal of Clinical. 16, e242 (2009)
  • [22] D. Chan, B. Bar-Oz, B. Pellerin, C. Paciorek, J. Klein, B. Kapur, D. Farine, G. Koren, Therapeutic Drug Monitoring. 25, 271 (2003)[Crossref]
  • [23] E.M. Ostrea Jr., J.D. Hernandez, D.M. Bielawski, J.M. Kan, G.M. Leonardo, M.B. Abela, M.W. Church, J.H. Hannigan, J.J. Janisse, J.W. Ager, R.J. Socol, Alcoholism: Clinical and Experimental Research 30, 1152 (2006)[Crossref]
  • [24] J.S. Noland, L.T. Singer, R.E. Arendt, S. Minnes, E.J. Short, C.F. Bearer, Alcoholism: Clinical and Experimental Research 27, 647 (2003)[Crossref]
  • [25] J. Peterson, H.L. Kirchner, W. Xue, S. Minnes, L.T. Singer, C.F. Bearer, The Journal of Pediatrics 152, 788 (2008)[Crossref]
  • [26] C. Moore, J. Jones, D. Lewis, K. Buchi, Clinical Chemistry 49, 133 (2003)[Crossref]
  • [27] Centers for Disease Control and Prevention: Alcohol consumption among women who are pregnant or who might become pregnant. US Morbidity and Mortality Weekly Report (MMWR) 53, 1178 (2002)
  • [28] M. Zaffanello, C. Maffeis, G. Zamboni, Journal of Perinatal Medicine 33, 246 (2005)[Crossref]
  • [29] A.P. Streissguth, F.L. Bookstein, H.M. Barr, P.D. Sampson, K. O’Malley, J.K. Young, Journal of Developmental and Behavioral Pediatrics 25, 228 (2004)[Crossref]
  • [30] C.F. Bearer, S. Lee, A.E. Salvator, S. Minnes, A. Swick, T. Yamashita, L.T. Singer, Alcoholism: Clinical and Experimental Research 23, 487 (1999)
  • [31] I. Zelner, J.R. Hutson, B.M. Kapur, D.S. Feig, G. Koren, Alcoholism: Clinical and Experimental Research 36, 1497 (2012)[Crossref]
  • [32] L. Burd, R. Hofer, Birth Defects Research 82, 487 (2008)[Crossref]
  • [33] S. Pichini, M. Pellegrini, J. Gareri, G. Koren, O. Garcia-Algar, O. Vall, F. Vagnarelli, P. Zuccaro, E. Marchei, Journal of Pharmaceutical and Biomedical Analysis 48, 927 (2008)[Crossref]
  • [34] H.-S. Kwak, Y.-S. Kang, K.-O. Han, J.-T. Moon, Y.-C. Chung, J.-S. Choi, J.-Y. Han, M.-Y. Kim, E. Yadir, V. Armenta, A.A. Nava-Ocampo, Journal of Chromatography B 878, 1871 (2010)[Crossref]
  • [35] G. Koren, I. Nulman, A.E. Chudley, C. Loocke, Canadian Medical Asosiation Journal (CMAJ) 169, 1181 (2003)
  • [36] R. Mojtabai, P. Singh, American Journal on Addictions 16, 300 (2007)[Crossref]
  • [37] Substance Abuse and Menthal Health Services Administration. Results from the 2007 National Survey on Drug Use and Health: national Findings. NSDUH Series H-34-DHHS Publication No. SMA (Office of Applied Studies, 08-4343, Rockville, MD, 2008)
  • [38] H.E. Jones, M.L. Velez, M.E. McCaul, D.S. Svikis, E.C. Strain, M.L. Stitzer (Eds.), Methadone Treatment for Opioid Dependence (The Johns Hopkins University Press, Baltimore, 1999) 251
  • [39] M.A. Huestis, R.E. Choo, Forensic Science International 128, 20 (2002)[Crossref]
  • [40] G. Hoegerman, S. Schnoll, Clinics in Perinatology 18, 51 (1991)
  • [41] G.A. Richardson, S.C. Hamel, L. Goldschmidt, N.L. Day, Neurotoxicology and Teratology 18, 519 (1996)[Crossref]
  • [42] G.A. Richardson, L. Goldschmidt, J. Willford, Neurotoxicology and Teratology 30, 96 (2008)[Crossref]
  • [43] M. Daley, M. Argeriou, D. McCarty, J.J. Callahan, D.S. Shepard, C.N. Williams, Journal of Psychoactive Drugs 33, 57 (2001)[Crossref]
  • [44] C. McMurtrie, K.D. Rosenberg, B.D. Kerker, J. Kan, E.H. Graham, American Journal of Drug and Alcohol Abuse 25, 701 (1999)[Crossref]
  • [45] D.S. Svikis, J.H. Lee, N.A. Haug, M.L. Stitzer, Drug and Alcohol Dependence 48, 33 (1997)[Crossref]
  • [46] R. Arlettaz, M. Kashiwagi, S. Das-Kundu, J.C. Fauchere, A. Lang, H.U. Bucher, Acta Obstetricia et Gynecologica Scandinavica 84, 145 (2005) [Crossref]
  • [47] L. Burns, R.P. Mattick, Drug and Alcohol Review 26, 487 (2007)[Crossref]
  • [48] F. Moriya, K-M Chan, T.T. Noguchi, P.Y.K. Wu, Journal of Analytical Toxicology 18, 41 (1994) [Crossref]
  • [49] T. Gray, M. Huestis, Analytical and Bioanalytical Chemistry 388, 1455 (2007)[Crossref]
  • [50] J. Lozano, O. Garcia-Algar, O. Vall, R. de la Torre, G. Scaravelli, S. Pichini, Therapeutic Drug Monitoring 29, 711 (2007)[Crossref]
  • [51] A. de Castro, M. Concheiro, D.M. Shakleya, M.A. Huestis, Journal of Chromatography B. 877, 3065 (2009)[Crossref]
  • [52] G.A. Richardson, M.A. Huestis, N.L. Day, In: D.C. Bellinger (Ed.), Human Developmental Neurotoxicology (Taylor and Francis Group, New York, 2006) 287
  • [53] E.M. Ostrea, P.M. Parks, M.J. Brady, Clinical Chemistry 34, 2372 (1988)
  • [54] G. Koren, D. Chan, J. Klein, T. Karaskov, Therapeutic Drug Monitoring 24, 23 (2002)[Crossref]
  • [55] C. Moore, A. Negrusz, D. Lewis, Journal of Chromatography B 713, 137 (1988)[Crossref]
  • [56] D.P. Montgomery, C.A. Plate, S.C. Alder, M. Jones, J. Jones, R.D. Christensen, Journal of Perinatology 26, 11 (2006)[Crossref]
  • [57] D. P. Montgomery, C.A. Plate, M. Jones, J. Jones, R. Rios, D.K. Lambert, N. Schumtz, S.E. Wiedmeier, J. Burnett, S. Ail, D. Brandel, G. Maichuck, C.A. Durham, E. Henry, R.D. Christensen, Journal of Perinatology 28, 750 (2008)[Crossref]
  • [58] R.E. Winecker, B.A. Goldberger, I. Tebbett, M. Behnke, F.D. Eyler, M. Conlon, K. Wobie, J. Karlix, R.L. Bertholf, Journal of Analytical Toxicology 21, 97 (1997) [Crossref]
  • [59] C.M. Moore, S. Brown, A. Negrusz, I. Tebbett, W. Meyer, L. Jain, Journal of Analytical Toxicology 17, 62 (1993) [Crossref]
  • [60] Official journal of the European Communities L 221, 8 (2002)
  • [61] S. Zhang, S.R. Mada, D. Mattison, S. Caritis, R. Venkataramanan, Journal of Chromatography B 856, 141 (2007)[Crossref]
  • [62] N.S. Paneth, Future Child 5, 19 (1995)[Crossref]
  • [63] D.R. Mattison, K. Damus, E. Fiore, J. Petrinni, C. Alter, Paediatric and Perinatal Epidemiology 15, 7 (2001)[Crossref]
  • [64] P.J. Meis, Obstetrics and Gynecology 105, 1128 (2005)[Crossref]
  • [65] J.R. Petrini, W.M. Callaghan, M. William, M. Klebanoff, N. Green, E. Lackritz, J. Howse, R. Schwarz, K. Damus, Obstetrics and Gynecology 105, 267 (2005)[Crossref]
  • [66] L. Sanchez-Ramos, A.M. Kaunitz, I. Delke, Obstetrics and Gynecology 105, 273 (2005)[Crossref]
  • [67] N.K. Levtchenko, D.M. Osokin, I.V. Torgov, A.P. Arzamastzev, T.M. Sokolova, G.I. Tuguntaev, Journal of Chromatography A 456, 427 (1986)[Crossref]
  • [68] V. Das Gupta, Journal of Pharmaceutical Sciences 71, 294 (1982)[Crossref]
  • [69] A.R. McKinney, C.J. Suann, A.M. Stenhouse, Rapid Communications in Mass Spectrometry 201, 855 (2006)
  • [70] T. Higashi, M. Tobiyama, F. Horita, M. Sajimoto, K. Shimada, K. Tanaka, H. Honjo, Journal of Liquid Chromatography and Related Technologies 24, 509 (2001)[Crossref]
  • [71] H. Honjo, Y. Yamamoto, T. Yamamoto, E. Kato, K. Ohtsubo, T. Ohshima, T. Yamamoto, M. Ishihara, K. Okada, Clinical Endocrinology 25, 1355 (1977)
  • [72] L.D. Bowers, Journal of Chromatography B 687, 61 (1996)[Crossref]
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.